IBDEI0TL ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13876,1,4,0)
 ;;=4^G56.21
 ;;^UTILITY(U,$J,358.3,13876,2)
 ;;=^5004024
 ;;^UTILITY(U,$J,358.3,13877,0)
 ;;=G56.22^^53^599^55
 ;;^UTILITY(U,$J,358.3,13877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13877,1,3,0)
 ;;=3^Lesion of Ulnar Nerve,Left Upper Limb
 ;;^UTILITY(U,$J,358.3,13877,1,4,0)
 ;;=4^G56.22
 ;;^UTILITY(U,$J,358.3,13877,2)
 ;;=^5004025
 ;;^UTILITY(U,$J,358.3,13878,0)
 ;;=M26.60^^53^599^180
 ;;^UTILITY(U,$J,358.3,13878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13878,1,3,0)
 ;;=3^Temporomandibular Joint Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,13878,1,4,0)
 ;;=4^M26.60
 ;;^UTILITY(U,$J,358.3,13878,2)
 ;;=^5011714
 ;;^UTILITY(U,$J,358.3,13879,0)
 ;;=L40.52^^53^599^137
 ;;^UTILITY(U,$J,358.3,13879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13879,1,3,0)
 ;;=3^Psoriatic Arthritis Mutilans
 ;;^UTILITY(U,$J,358.3,13879,1,4,0)
 ;;=4^L40.52
 ;;^UTILITY(U,$J,358.3,13879,2)
 ;;=^5009167
 ;;^UTILITY(U,$J,358.3,13880,0)
 ;;=L40.53^^53^599^138
 ;;^UTILITY(U,$J,358.3,13880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13880,1,3,0)
 ;;=3^Psoriatic Spondylitis
 ;;^UTILITY(U,$J,358.3,13880,1,4,0)
 ;;=4^L40.53
 ;;^UTILITY(U,$J,358.3,13880,2)
 ;;=^5009168
 ;;^UTILITY(U,$J,358.3,13881,0)
 ;;=M32.9^^53^599^179
 ;;^UTILITY(U,$J,358.3,13881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13881,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Unspec
 ;;^UTILITY(U,$J,358.3,13881,1,4,0)
 ;;=4^M32.9
 ;;^UTILITY(U,$J,358.3,13881,2)
 ;;=^5011761
 ;;^UTILITY(U,$J,358.3,13882,0)
 ;;=M32.0^^53^599^175
 ;;^UTILITY(U,$J,358.3,13882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13882,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Drug-Induced
 ;;^UTILITY(U,$J,358.3,13882,1,4,0)
 ;;=4^M32.0
 ;;^UTILITY(U,$J,358.3,13882,2)
 ;;=^5011752
 ;;^UTILITY(U,$J,358.3,13883,0)
 ;;=M32.13^^53^599^177
 ;;^UTILITY(U,$J,358.3,13883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13883,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Lung Involvement
 ;;^UTILITY(U,$J,358.3,13883,1,4,0)
 ;;=4^M32.13
 ;;^UTILITY(U,$J,358.3,13883,2)
 ;;=^5011756
 ;;^UTILITY(U,$J,358.3,13884,0)
 ;;=M32.14^^53^599^176
 ;;^UTILITY(U,$J,358.3,13884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13884,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Glomerular Disease
 ;;^UTILITY(U,$J,358.3,13884,1,4,0)
 ;;=4^M32.14
 ;;^UTILITY(U,$J,358.3,13884,2)
 ;;=^5011757
 ;;^UTILITY(U,$J,358.3,13885,0)
 ;;=M32.12^^53^599^178
 ;;^UTILITY(U,$J,358.3,13885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13885,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Pericarditis
 ;;^UTILITY(U,$J,358.3,13885,1,4,0)
 ;;=4^M32.12
 ;;^UTILITY(U,$J,358.3,13885,2)
 ;;=^5011755
 ;;^UTILITY(U,$J,358.3,13886,0)
 ;;=M05.59^^53^599^159
 ;;^UTILITY(U,$J,358.3,13886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13886,1,3,0)
 ;;=3^Rheumatoid Polyneuropathy w/ Rheumatoid Arthritis of Mult Sites
 ;;^UTILITY(U,$J,358.3,13886,1,4,0)
 ;;=4^M05.59
 ;;^UTILITY(U,$J,358.3,13886,2)
 ;;=^5009976
 ;;^UTILITY(U,$J,358.3,13887,0)
 ;;=M05.711^^53^599^153
 ;;^UTILITY(U,$J,358.3,13887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13887,1,3,0)
 ;;=3^Rheumatoid Arthritis of Right Shoulder
 ;;^UTILITY(U,$J,358.3,13887,1,4,0)
 ;;=4^M05.711
 ;;^UTILITY(U,$J,358.3,13887,2)
 ;;=^5010001
 ;;^UTILITY(U,$J,358.3,13888,0)
 ;;=M05.712^^53^599^146
 ;;^UTILITY(U,$J,358.3,13888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13888,1,3,0)
 ;;=3^Rheumatoid Arthritis of Left Shoulder
 ;;^UTILITY(U,$J,358.3,13888,1,4,0)
 ;;=4^M05.712
 ;;^UTILITY(U,$J,358.3,13888,2)
 ;;=^5010002
 ;;^UTILITY(U,$J,358.3,13889,0)
 ;;=M05.731^^53^599^154
 ;;^UTILITY(U,$J,358.3,13889,1,0)
 ;;=^358.31IA^4^2
